Anita Marie Roberts

age ~64

from Bristow, OK

Get Report

Also known as:

Anita M Roberts
Anita Marie Sparks
Danny L Roberts
Nita Roberts
Amita M Roberts
Anita S Parks
Anita Robinson

Connected to:

Anita Roberts Phones & Addresses

Bristow, OK
Broomfield, CO
Troy, MO
Ashland, MS
Laurel, MD
Columbia, SC
Collinsville, MS

Specialities

Buyer's Agent • Listing Agent

Isbn (Books And Publications)

The Last Chance Cafe

view source

Author
Anita Roberts

ISBN #
0919591809

The Retinoids

view source

Author
Anita B. Roberts

ISBN #
0126581010

The Retinoids

view source

Author
Anita B. Roberts

ISBN #
0126581029

Peptide Growth Factors and Their Receptors I

view source

Author
Anita B. Roberts

ISBN #
0387511849

Peptide Growth Factors and Their Receptors

view source

Author
Anita B. Roberts

ISBN #
0387511857

Peptide Growth Factors and Their Receptors

view source

Author
Anita B. Roberts

ISBN #
0387977295

Peptide Growth Factors and Their Receptors, I & II

view source

Author
Anita B. Roberts

ISBN #
0387976949

The Retinoids: Biology, Chemistry, and Medicine

view source

Author
Anita B. Roberts

ISBN #
0781700825

Name / Title

Company / Classification

Phones & Addresses

Anita Roberts
Associate

O'Melveny & Myers Llp
Legal Services Office

1625 Interstate St NW, Washington, DC 20006
1625 I St NW, Washington, DC 20006
(202)3835300

Anita C. Roberts

PHARM HANDZ, LC

Anita Roberts

SCOTT ROBERTS ROOFING & CONSTRUCTION, INC

License Records

Anita Marie Roberts

Address:

13650 Plaster Cir, Broomfield, CO 80023

License #:

21867 - Expired

Issued Date:

Nov 25, 1983

Renew Date:

Jun 30, 1986

Expiration Date:

Jun 30, 1986

Type:

Licensed Practical Nurse

Anita Marie Roberts

Address:

13650 Plaster Cir, Broomfield, CO 80023

License #:

84075 - Active

Issued Date:

Aug 20, 1986

Renew Date:

Oct 1, 2015

Expiration Date:

Sep 30, 2017

Type:

Registered Nurse

Us Patents

Novel Human Septin And Uses Therefor
view source
US Patent:

20030124571, Jul 3, 2003
Filed:

Jul 29, 2002
Appl. No.:

10/208304
Inventors:

Sarit Larisch - Zichron-Yaakov, IL
Seong-Jin Kim - Bethesda MD, US
Robert Lechleider - Bethesda MD, US
Anita Roberts - Bethesda MD, US
Youngsuk Yi - Redwood City CA, US
Assignee:

The Government of the United States of America - Rockville MD
International Classification:

C12Q001/68
C07H021/04
C12N009/64
C12P021/02
C12N005/06
US Classification:

435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:

The invention provides a newly identified and isolated nucleotide sequence encoding a polypeptide referred to in the present application as ARTS, for Apoptosis Related protein in the TGF- Signaling pathway.

Inhibition Of Smad3 To Prevent Fibrosis And Improve Wound Healing
view source
US Patent:

20030139366, Jul 24, 2003
Filed:

Nov 18, 2002
Appl. No.:

10/299886
Inventors:

Anita Roberts - Bethesda MD, US
Gillian Ashcroft - Lancashire, GB
Angelo Russo - Bethesda MD, US
James Mitchell - Damascus MD, US
International Classification:

A61K048/00
A61K038/17
US Classification:

514/044000, 514/012000
Abstract:

The invention is related to modulation of Smad3 expression to prevent fibrosis and improve wound healing. Aspects of the invention, for example, include approaches to improve wound healing and/or reduce or prevent fibrosis by inhibiting Smad3. Embodiments described herein also include approaches to identify componds that modulate Smad3 expression and the preparation of pharmaceuticals comprising said compounds.

Use Of Smad3 Inhibitor In The Treatment Of Fibrosis Dependent On Epithelial To Mesenchymal Transition As In The Eye And Kidney
view source
US Patent:

20060040253, Feb 23, 2006
Filed:

Jul 15, 2005
Appl. No.:

11/183194
Inventors:

Anita Roberts - Bethesda MD, US
Shizuya Saika - Wakayama, JP
International Classification:

A61K 48/00
C12Q 1/00
US Classification:

435004000, 514044000
Abstract:

The invention is related to inhibition of Smad3 to ameliorate Smad3 mediated epithelial to mesenchymal transition.

Inhibition Of Smad3 To Prevent Fibrosis And Improve Wound Healing
view source
US Patent:

20060079449, Apr 13, 2006
Filed:

Dec 9, 2005
Appl. No.:

11/299122
Inventors:

Anita Roberts - Bethesda MD, US
Gillian Ashcroft - Lancashire, GB
Angelo Russo - Bethesda MD, US
James Mitchell - Damascus MD, US
International Classification:

A61K 48/00
A61K 38/54
US Classification:

514002000, 514044000
Abstract:

The invention is related to modulation of Smad3 expression to prevent fibrosis and improve wound healing. Aspects of the invention, for example, include approaches to improve wound healing and/or reduce or prevent fibrosis by inhibiting Smad3. Embodiments described herein also include approaches to identify componds that modulate Smad3 expression and the preparation of pharmaceuticals comprising said compounds.

Purified Transforming Growth Factor Beta
view source
US Patent:

51049775, Apr 14, 1992
Filed:

Feb 8, 1989
Appl. No.:

7/308948
Inventors:

Michael B. Sporn - Bethesda MD
Anita B. Roberts - Bethesda MD
Richard K. Assoian - Dobbs Ferry NY
Charles A. Frolik - Indianapolis IN
Assignee:

The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:

C07K 1500
US Classification:

530399
Abstract:

A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-. beta. which is activated by either a TGF-. alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.

Compositions Of Transforming Growth Factor .Beta.(Tgf-.Beta.) Which Promotes Wound Healing And Methods For Their Use
view source
US Patent:

57054770, Jan 6, 1998
Filed:

Jul 5, 1994
Appl. No.:

8/267227
Inventors:

Michael B. Sporn - Bethesda MD
Anita B. Roberts - Bethesda MD
Assignee:

The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:

A61K 3818
C07K 14495
US Classification:

514 2
Abstract:

A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-. beta. which is activated by either a TGF-. alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.

Promotion Of Cell Proliferation By Use Of Transforming Growth Factor Beta (Tgf-.Beta.)
view source
US Patent:

56565879, Aug 12, 1997
Filed:

Apr 16, 1993
Appl. No.:

8/048956
Inventors:

Michael B. Sporn - Bethesda MD
Anita B. Roberts - Bethesda MD
Assignee:

The United States of America as represented by the Secretary of the
Department of Health and Human Services - Washington DC
International Classification:

A61K 3818
C07K 14495
US Classification:

514 2
Abstract:

A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-. beta. which is activated by either a TGF-. alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.